Related references
Note: Only part of the references are listed.NF-κB-inducing kinase maintains T cell metabolic fitness in antitumor immunity
Meidi Gu et al.
NATURE IMMUNOLOGY (2021)
A metabolic switch to memory CAR T cells: Implications for cancer treatment
Hosein Rostamian et al.
CANCER LETTERS (2021)
Mitochondria as multifaceted regulators of cell death
Florian J. Bock et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
Sarwish Rafiq et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8+ T cell stemness and antitumor immunity
Dalton Hermans et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Signaling networks in immunometabolism
Jordy Saravia et al.
CELL RESEARCH (2020)
Genetic and pharmacological targeting of A2a receptor improves function of anti-mesothelin CAR T cells
Elham Masoumi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Regulation of human Mcl-1 by a divergently-expressed antisense transcript
S. M. Ali Hosseini Rad et al.
GENE (2020)
CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape
Alba Rodriguez-Garcia et al.
FRONTIERS IN IMMUNOLOGY (2020)
Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen
Santosha A. Vardhana et al.
NATURE IMMUNOLOGY (2020)
CRISPR-Cas9 DNA Base-Editing and Prime-Editing
Ariel Kantor et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
T-cells produce acidic niches in lymph nodes to suppress their own effector functions
Hao Wu et al.
NATURE COMMUNICATIONS (2020)
ENHANCING CAR T CELL PERSISTENCE AND MEMORY THROUGH MODULATING MITOCHONDRIAL FUNCTION
A. Hosseini Rad et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Compact Bidirectional Promoters for Dual-Gene Expression in a Sleeping Beauty Transposon
Kevin He et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
BCMA-TARGETING CAR-T CELLS EXPANDED IN IL-15 HAVE AN IMPROVED PHENOTYPE FOR THERAPEUTIC USE COMPARED TO THOSE GROWN IN IL-2 OR IL-15/IL-7
Anthony Battram et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Efficacy and safety of second-generation CAR T-cell therapy in diffuse large B-cell lymphoma: A meta-analysis
Mubarak Al-Mansour et al.
MOLECULAR AND CLINICAL ONCOLOGY (2020)
TGF-β inhibition via CRISPR promotes the long-term efficacy of CAR T cells against solid tumors
Na Tang et al.
JCI INSIGHT (2020)
Metabolic coordination of T cell quiescence and activation
Nicole M. Chapman et al.
NATURE REVIEWS IMMUNOLOGY (2020)
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy
Tori N. Yamamoto et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy
Jaco A. C. van Bruggen et al.
BLOOD (2019)
Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment
Xingzhe Ma et al.
CELL METABOLISM (2019)
GLUCOSE DEPRIVATION ENRICHES FOR CENTRAL MEMORY T CELLS DURING CHIMERIC ANTIGEN RECEPTOR-T CELL EXPANSION
A. Amini et al.
CYTOTHERAPY (2019)
Chimeric antigen receptor T cell persistence and memory cell formation
Alexander D. McLellan et al.
IMMUNOLOGY AND CELL BIOLOGY (2019)
Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3-Targeted Chimeric Antigen Receptor-Engineered T Cells in Hepatocellular Carcinoma
Ying Liu et al.
JOURNAL OF IMMUNOLOGY (2019)
A Metabolism Toolbox for CAR T Therapy
Xuequn Xu et al.
FRONTIERS IN ONCOLOGY (2019)
Linking mitochondrial dynamics, cristae remodeling and supercomplex formation: How mitochondrial structure can regulate bioenergetics
Nicole Baker et al.
MITOCHONDRION (2019)
PD-1 silencing impairs the anti-tumor function of chimeric antigen receptor modified T cells by inhibiting proliferation activity
Jianshu Wei et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Reactive Oxygen Species in the Tumor Microenvironment: An Overview
Frank Weinberg et al.
CANCERS (2019)
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Robert D. Leone et al.
SCIENCE (2019)
Teaching an old dog new tricks: next-generation CAR T cells
Nicholas Tokarew et al.
BRITISH JOURNAL OF CANCER (2019)
Mitochondrial complex III is essential for suppressive function of regulatory T cells
Samuel E. Weinberg et al.
NATURE (2019)
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Stephen J. Schuster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Lactate modulates CD4+ T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis
G. Comito et al.
ONCOGENE (2019)
Chimeric antigen receptors designed to overcome transforming growth factor-β-mediated repression in the adoptive T-cell therapy of solid tumors
Jordan Hartley et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2019)
Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines
Connor J. Dwyer et al.
FRONTIERS IN IMMUNOLOGY (2019)
Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerations
Robert Weinkove et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2019)
NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism
Wusheng Xiao et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
Cancer immunotherapy-induced endocrinopathies: Clinical behavior and therapeutic approach
Pedro Iglesias
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Post-Transcriptional Regulation of Anti-Apoptotic BCL2 Family Members
Jia Cui et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses
Ashley V. Menk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
PI3K orchestration of the in vivo persistence of chimeric antigen receptor-modified T cells
Wenting Zheng et al.
LEUKEMIA (2018)
Mitochondrial activity in T cells
Gabriela Desdin-Mico et al.
MITOCHONDRION (2018)
In Vivo Expansion and Antitumor Activity of Coinfused CD28-and 4-1BB-Engineered CAR-T Cells in Patients with B Cell Leukemia
Zhi Cheng et al.
MOLECULAR THERAPY (2018)
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Joseph A. Fraietta et al.
NATURE MEDICINE (2018)
Hexokinase II may be dispensable for CD4 T cell responses against a virus infection
Siva Karthik Varanasi et al.
PLOS ONE (2018)
Mitochondria-associated membranes (MAMs) and inflammation
Sonia Missiroli et al.
CELL DEATH & DISEASE (2018)
CARs versus BiTEs: A Comparison between T Cell-Redirection Strategies for Cancer Treatment
Clare Y. Slaney et al.
CANCER DISCOVERY (2018)
IL-21 modulates memory and exhaustion phenotype of T-cells in a fatty acid oxidation-dependent manner
Romy Loschinski et al.
Oncotarget (2018)
Mitochondria! Morphological and Functional Reprogramming Following CD137 (4-1BB) Costimulation
Alvaro Teijeira et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cell Engineered to Target B Cell Follicles and Suppress SIV Replication
Kumudhini Preethi Haran et al.
FRONTIERS IN IMMUNOLOGY (2018)
Glutathione de novo synthesis but not recycling process coordinates with glutamine catabolism to control redox homeostasis and directs murine T cell differentiation
Gaojian Lian et al.
ELIFE (2018)
CD30-Redirected Chimeric Antigen Receptor T Cells Target CD30+ and CD30- Embryonal Carcinoma via Antigen-Dependent and Fas/FasL Interactions
Lee K. Hong et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Reinforce the antitumor activity of CD8+ T cells via glutamine restriction
Shogo Nabe et al.
CANCER SCIENCE (2018)
Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance
Michael M. Boyiadzis et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Hexokinase 2 is dispensable for T cell-dependent immunity
Manan M. Mehta et al.
CANCER & METABOLISM (2018)
Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect
Martin Felices et al.
JCI INSIGHT (2018)
The spectrum of T cell metabolism in health and disease
Glenn R. Bantug et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
Nicole E. Scharping et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Integrative Proteomics and Phosphoproteomics Profiling Reveals Dynamic Signaling Networks and Bioenergetics Pathways Underlying T Cell Activation
Haiyan Tan et al.
IMMUNITY (2017)
Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy
James N. Kochenderfer et al.
MOLECULAR THERAPY (2017)
Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies
David J. Byun et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
Kenji Chamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Amino-acid transporters in T-cell activation and differentiation
W. Ren et al.
CELL DEATH & DISEASE (2017)
Mitochondrial Control and Guidance of Cellular Activities of T Cells
Tung Chao et al.
FRONTIERS IN IMMUNOLOGY (2017)
CD95/Fas, Non-Apoptotic Signaling Pathways, and Kinases
Matthieu Le Gallo et al.
FRONTIERS IN IMMUNOLOGY (2017)
Nutrient and Metabolic Sensing in T Cell Responses
Jun Wei et al.
FRONTIERS IN IMMUNOLOGY (2017)
Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy
Christopher A. Klebanoff et al.
JCI INSIGHT (2017)
Nutritional effects on T-cell immunometabolism
Sivan Cohen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies
Kristin G. Anderson et al.
CANCER CELL (2017)
Glutamine Metabolism in Cancer: Understanding the Heterogeneity
Ahmad A. Cluntun et al.
TRENDS IN CANCER (2017)
Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy
Christopher A. Klebanoff et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Coexpressed Catalase Protects Chimeric Antigen Receptor-Redirected T Cells as well as Bystander Cells from Oxidative Stress-Induced Loss of Antitumor Activity
Maarten A. Ligtenberg et al.
JOURNAL OF IMMUNOLOGY (2016)
Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming
Michael D. Buck et al.
CELL (2016)
Combination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling
Andy J. Minn et al.
CELL (2016)
Mitochondrial Biogenesis and Proteome Remodeling Promote One-Carbon Metabolism for T Cell Activation
Noga Ron-Harel et al.
CELL METABOLISM (2016)
Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity
Rob J. W. Arts et al.
CELL METABOLISM (2016)
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
Almut Brand et al.
Cell Metabolism (2016)
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
Omkar U. Kawalekar et al.
IMMUNITY (2016)
AIF Is Always In Fashion'' for T Cells
Marc O. Johnson et al.
IMMUNITY (2016)
mTORC1 and mTORC2 Kinase Signaling and Glucose Metabolism Drive Follicular Helper T Cell Differentiation
Hu Zeng et al.
IMMUNITY (2016)
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
Nicole E. Scharping et al.
IMMUNITY (2016)
Suppression of Glut1 and Glucose Metabolism by Decreased Akt/mTORC1 Signaling Drives T Cell Impairment in B Cell Leukemia
Peter J. Siska et al.
JOURNAL OF IMMUNOLOGY (2016)
Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism
Wei Yang et al.
NATURE (2016)
Augmentation of CAR T-cell Trafficking and Antitumor Efficacy by Blocking Protein Kinase A Localization
Kheng Newick et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Hypoxia and antitumor CD8+ T cells: An incompatible alliance?
Romain Vuillefroy de Silly et al.
ONCOIMMUNOLOGY (2016)
Early T Cell Activation: integrating Biochemical, Structural, and Biophysical Cues
Bernard Malissen et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
IL-7-Induced Glycerol Transport and TAG Synthesis Promotes Memory CD8+ T Cell Longevity
Guoliang Cui et al.
CELL (2015)
The role of CD95 and CD95 ligand in cancer
M. E. Peter et al.
CELL DEATH AND DIFFERENTIATION (2015)
Mitochondrial Respiration Controls Lysosomal Function during Inflammatory T Cell Responses
Francesc Baixauli et al.
CELL METABOLISM (2015)
Phenotypic switch of CD8+ T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells
Romain Vuillefroy de Silly et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
T cell metabolism drives immunity
Michael D. Buck et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Targeting mitochondria metabolism for cancer therapy
Samuel E. Weinberg et al.
NATURE CHEMICAL BIOLOGY (2015)
T lymphocyte regulation by mevalonate metabolism
Martin Thurnher et al.
SCIENCE SIGNALING (2015)
Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation
Dorota Klysz et al.
SCIENCE SIGNALING (2015)
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
David L. Porter et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
T lymphocyte regulation by mevalonate metabolism
Martin Thurnher et al.
SCIENCE SIGNALING (2015)
Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation
Dorota Klysz et al.
SCIENCE SIGNALING (2015)
Functional Tuning of CARs Reveals Signaling Threshold above Which CD8+ CTL Antitumor Potency Is Attenuated due to Cell Fas-FasL-Dependent AICD
Annette Kuenkele et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Inflammatory T Cell Responses Rely on Amino Acid Transporter ASCT2 Facilitation of Glutamine Uptake and mTORC1 Kinase Activation
Mako Nakaya et al.
IMMUNITY (2014)
HIF Transcription Factors, Inflammation, and Immunity
Asis Palazon et al.
IMMUNITY (2014)
Targeting glutamine transport to suppress melanoma cell growth
Qian Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Death Induced by CD95 or CD95 Ligand Elimination
Abbas Hadji et al.
CELL REPORTS (2014)
Out of the bitter came forth sweet Activating CD28-dependent co-stimulation via PD-1 ligands
Chen Ankri et al.
ONCOIMMUNOLOGY (2014)
Mitochondria Are Required for Antigen-Specific T Cell Activation through Reactive Oxygen Species Signaling
Laura A. Sena et al.
IMMUNITY (2013)
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
Madhusudhanan Sukumar et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
TGF-β: Guardian of T Cell Function
Soyoung A. Oh et al.
JOURNAL OF IMMUNOLOGY (2013)
Human T Cells Engineered To Express a Programmed Death 1/28 Costimulatory Retargeting Molecule Display Enhanced Antitumor Activity
Chen Ankri et al.
JOURNAL OF IMMUNOLOGY (2013)
IL-7 signaling must be intermittent, not continuous, during CD8+ T cell homeostasis to promote cell survival instead of cell death
Motoko Y. Kimura et al.
NATURE IMMUNOLOGY (2013)
Delving deeper: MCL-1's contributions to normal and cancer biology
Rhonda M. Perciavalle et al.
TRENDS IN CELL BIOLOGY (2013)
Stomatin-like Protein 2 Deficiency in T Cells Is Associated with Altered Mitochondrial Respiration and Defective CD4+ T Cell Responses
Darah A. Christie et al.
JOURNAL OF IMMUNOLOGY (2012)
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Christian M. Metallo et al.
NATURE (2012)
Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration
Rhonda M. Perciavalle et al.
NATURE CELL BIOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Modulation of CD4+ T-cell activation by CD95 co-stimulation
M. Paulsen et al.
CELL DEATH AND DIFFERENTIATION (2011)
Acetyl-CoA Induces Cell Growth and Proliferation by Promoting the Acetylation of Histones at Growth Genes
Ling Cai et al.
MOLECULAR CELL (2011)
A human memory T cell subset with stem cell-like properties
Luca Gattinoni et al.
NATURE MEDICINE (2011)
Mitochondrial cell death effectors
Dirk Brenner et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
NAD+/ NADH and NADP+/NADPH in cellular functions and cell death:: Regulation and biological consequences
Weihai Ying
ANTIOXIDANTS & REDOX SIGNALING (2008)
The CD95 receptor: Apoptosis revisited
Marcus E. Peter et al.
CELL (2007)
Caspase-8- and JNK-dependent AP-1 activation is required for Fas ligand-induced IL-8 production
Norihiko Matsumoto et al.
FEBS JOURNAL (2007)
Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies
Hyungjin Kim et al.
NATURE CELL BIOLOGY (2006)
A2A adenosine receptor protects tumors from antitumor T cells
Akio Ohta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells
BC Barnhart et al.
EMBO JOURNAL (2004)
Production of ribosome components in effector CD4+ T cells is accelerated by TCR stimulation and coordinated by ERK-MAPK
M Asmal et al.
IMMUNITY (2003)
Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-Resistant, long-term activated, antigen-specific T cells
G Strauss et al.
JOURNAL OF IMMUNOLOGY (2003)
Defining characteristics of Types I and II apoptotic cells in response to TRAIL
N Özören et al.
NEOPLASIA (2002)
Gene transfer of a chimeric trans-activator is immunogenic and results in short-lived transgene expression
M Latta-Mahieu et al.
HUMAN GENE THERAPY (2002)
Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells
L Gorelik et al.
NATURE MEDICINE (2001)
CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression
P Kirk et al.
EMBO JOURNAL (2000)
Share Paper
